Does off-pump CABG reduce the 30-day rate of death, myocardial infarction, stroke, or renal failure requiring dialysis compared to on-pump CABG?
At 30 days, off-pump CABG showed no significant difference in major composite clinical outcomes compared to on-pump CABG, though it altered the profile of perioperative complications.
There was no significant difference between off-pump and on-pump CABG with respect to the 30-day rate of death, myocardial infarction, stroke, or renal failure requiring dialysis. The use of off-pump CABG resulted in reduced rates of transfusion, reoperation for perioperative bleeding, respiratory complications, and acute kidney injury but also resulted in an increased risk of early revascularization. (Funded by the Canadian Institutes of Health Research; CORONARY ClinicalTrials.gov number, NCT00463294.).
Lamy et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: